Brinker Capital Investments’s Cytokinetics CYTK Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q2 | – | Sell |
-3,168
| Closed | -$222K | – | 1727 |
|
2024
Q1 | $222K | Buy |
+3,168
| New | +$222K | ﹤0.01% | 1577 |
|
2023
Q1 | – | Sell |
-4,847
| Closed | -$222K | – | 1577 |
|
2022
Q4 | $222K | Sell |
4,847
-34
| -0.7% | -$1.56K | ﹤0.01% | 1264 |
|
2022
Q3 | $236K | Sell |
4,881
-2,595
| -35% | -$125K | ﹤0.01% | 1214 |
|
2022
Q2 | $294K | Buy |
+7,476
| New | +$294K | 0.01% | 1172 |
|
2022
Q1 | – | Sell |
-4,446
| Closed | -$203K | – | 1384 |
|
2021
Q4 | $203K | Buy |
+4,446
| New | +$203K | ﹤0.01% | 1348 |
|